Digital marketing used to be about clicks, but the rise of ChatGPT means it's ‘now all about winning the mentions'
Some consumers are beginning to shop using ChatGPT, and digital marketing that's geared toward web searches must shift too, experts say.
The threat that generative AI poses to search engines was highlighted when Apple's senior vice president of services said Safari web browsing recently decreased for the first time in 20 years, attributing it to users switching to large language models.
While Google refuted these claims, saying its search engine continues 'to see overall query growth,' other data hints at ChatGPT's influence in shopping.
Between late October and mid January, Amazon.com was the most frequently visited domain referred from ChatGPT's search function, accounting for 9.13% of all traffic, according to a survey by Datos.
Overall, e-commerce domains received 12.65%, trailing news (21.42%) and academic (17.81%) domains, Datos said.
The increase in popularity to shop via AI alters a marketer's approach to get eyes on their brand.
Traditional marketing techniques revolve around search engine optimization (SEO) practices to create a better chance of showing up on a user's Google query.
To improve the odds that the search algorithm will raise a company's visibility on the web, SEO practices focus on keywords, a site's load time, and mobile-phone friendliness.
But marketers now have to optimize for an investigative query from LLMs, which will pull from online content and third-party mentions. That includes a brand's website and the general consensus on social media platforms like Reddit and X
'Until recently, digital marketing was all about winning the clicks. With the rise of LLMs, it is now all about winning the mentions,' Yaron Litwin, chief marketing officer of the Parent Control App, told Fortune.
Like retail brands, the CMO of the content-filtering software business has adopted AI marketing to get ahead of the trend.
And when it comes to searching for the top-rated running shoes, for example, it's 'more of a conversation,' Erik Huberman, CEO of Hawke Media, a Los Angeles-based marketing company, told Fortune.
The LLM will then give users options by explaining why each shoe is the best fit for that specific query.
While marketers are beginning to optimize for LLMs, Huberman said that the increase in ChatGPT shopping is 'not significant enough yet to really throw anyone off.'
'So we haven't seen like a drop in organic traffic that's anything concerning…no alarm bells have gone off, but we know it's coming, so we're prepping for it,' he added.
Hawke Media is partnering with Gumshoe, an AI optimization expert that helps marketers understand how their brands are perceived and talked about by LLMs by generating thousands of conversations using AI models.
As LLMs take a holistic approach, Pietryla PR & Marketing President Christine Wetzler told Fortune that brand reputation is now 'critical.'
'Credibility is being built outside your site now,' so companies must curate 'brand storytelling,' Wetzler said.
Brand storytelling echoes the brands voice, in digestible content for an LLM, like articles, blogs, or on-site customer reviews.
'This is your new digital billboard,' Mongoose Media CEO Lauren Petrullo told Fortune. 'If your company isn't correctly represented, AI will fill in the blanks often inaccurately.'
This story was originally featured on Fortune.com

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
19 minutes ago
- Yahoo
Cardinal Health expands urology focus with $1.9bn Solaris Health deal
US drug distributor Cardinal Health has signed a $1.9bn agreement to acquire a majority stake in Solaris Health from Lee Equity Partners. The deal aims to expand the Specialty Alliance, the distributor's multi-speciality management services organisation (MSO) platform, in which Cardinal will gain a stake of around 75%. The acquisition will also create the Urology Alliance, comprising a collaborative network of urology providers within Cardinal's Specialty Alliance MSO, as well as resonate with plans to expand the delivery of urological patient care. Cardinal's Solaris buyout complements its recent acquisitions of Urology America, Potomac Urology, and Academic Urology & Urogynaecology, signalling its urologic strategy. The transaction is expected to be completed by the end of this year, pending customary closing conditions. Cardinal Health CEO Jason Hollar stated that growing the Speciality Alliance is a 'top priority' for the company, with the latest urology purchase leaving it 'well-positioned to meet the comprehensive needs of community urologists through the robust combined capabilities of the Specialty Alliance, Specialty Networks and Cardinal Health'. Research indicates there is a shortage of urologists in the US, with 62% of US counties lacking a practising urologist and just one new urologist entering the field for every ten retiring. The figures lead to challenges in the broader field, including delayed diagnoses, increased rates of advanced-stage conditions, and significant health disparities, with these particularly pronounced in rural communities. GlobalData's senior medical analyst Selena Yu foresees Cardinal's acquisition as reflecting a shift from drug distribution with a 'lower profit margin, towards higher margin speciality care in urology'. Yu said: 'MSOs help streamline backend work like billing and staffing to allow for physicians to focus on care. 'Additionally, with a large network of specialists, patients can receive care in the same region by different care specialists, which will reduce wait times and improve care continuity. Additionally, the Cardinal Health Alliance has other specialities like oncology specialists, which makes referrals more streamlined.' Cardinal's acquisition coincided with the release of its Q4 2025 financials. The company's profits per share came in at $2.08, beating the forecasted $2.03, yet profits for the quarter came in at $60.2bn, below the $60.92bn forecast, prompting a pre-market stock drop of more than 11% on 12 August. Cardinal's share price has since recovered to a drop of around 6% to $147.05 per share, down from $157.66 per share at market close on 11 August. "Cardinal Health expands urology focus with $1.9bn Solaris Health deal" was originally created and published by Medical Device Network, a GlobalData owned brand. The information on this site has been included in good faith for general informational purposes only. It is not intended to amount to advice on which you should rely, and we give no representation, warranty or guarantee, whether express or implied as to its accuracy or completeness. You must obtain professional or specialist advice before taking, or refraining from, any action on the basis of the content on our site. Effettua l'accesso per consultare il tuo portafoglio
Yahoo
19 minutes ago
- Yahoo
Texas sues Eli Lilly for allegedly bribing providers to prescribe its medications
WASHINGTON (Reuters) -Texas Attorney General Ken Paxton on Tuesday sued U.S. drugmaker Eli Lilly for allegedly "bribing" providers to prescribe its medications. The attorney general's office said in a statement that the company bribed and illegally induced medical providers to prescribe its most profitable drugs, including the GLP-1 medications Mounjaro and Zepbound, used for weight loss and diabetes treatment. "Big Pharma compromised medical decision-making by engaging in an illegal kickback scheme," Attorney General Paxton said. The lawsuit builds upon Attorney General's previous legal action to hold drug manufacturers accountable for fraud and abuse, the statement added. Last year, Paxton had sued insulin manufacturers, including Lilly and pharmacy benefit managers (PBMs), alleging that manufacturers artificially raised the prices of insulin and then paid a significant, undisclosed portion back to the PBMs for preferential treatment in return. Eli Lilly did not immediately respond to a Reuters request for comment. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data

Yahoo
19 minutes ago
- Yahoo
US Equity Indexes Jump After July Inflation Boosts Fed Rate-Cut Expectations
US equity indexes jumped in midday trading Tuesday, with the Nasdaq Composite and S&P 500 hitting al